Quantcast
Home / Legal News / FDA panel is first key test for Biden COVID-19 booster plan

FDA panel is first key test for Biden COVID-19 booster plan

The Biden administration's embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *

*